|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Tirofiban#Contraindications]] |
| {{Tirofiban}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Contraindications==
| |
| AGGRASTAT is contraindicated in patients with:
| |
| | |
| *Severe [[hypersensitivity]] reaction to AGGRASTAT (i.e., anaphylactic reactions) [see Adverse Reactions (6.2)].
| |
| *A history of [[thrombocytopenia]] following prior exposure to AGGRASTAT [see Adverse Reactions (6.1)].
| |
| *Active internal bleeding or a history of bleeding diathesis, major surgical procedure or severe physical trauma within the previous month [see Adverse Reactions (6.1)]<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AGGRASTAT (TIROFIBAN) INJECTION, SOLUTION [MEDICURE INTERNATIONAL INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f | publisher = | date = | accessdate = 6 February 2014 }}</ref>
| |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Antiplatelet drugs]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |